Phase 2 BELIEVE study part B: Efficacy and safety of rilzabrutinib for patients with pemphigus vulgaris

D. F. Murrell, A. Patsatsi, P. Stavropoulos, S. Baum, T. Zeeli, J. S. Kern, R. Sinclair, A. Neale, P. Arora, P. B. Sugerman, G. Shi, V. P. Werth, F. Caux, P. Joly, on behalf of the BELIEVE Trial Investigators

Research output: Contribution to journalLetterOtherpeer-review

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)852-855
Number of pages4
JournalJournal of the European Academy of Dermatology and Venereology
Issue number10
Publication statusPublished - Oct 2022
Externally publishedYes


  • bullous disorders
  • disease control
  • pemphigus

Cite this